Listed

Stepan Co: Form 10-Q for the period ended Mar 31, 2020

Filed with the SEC on Apr 30, 2020 and accepted by EDGAR at Apr 30, 2020, 10:22 ET.

Share

Management's discussion and analysis

As filed, 53,106 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim periods included in the accompanying condensed consolidated financial statements.

Certain statements in this Quarterly Report on Form 10-Q, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include statements about Stepan Company’s and its subsidiaries’ (the Company) plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause the Company’s actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q.

Such risks, uncertainties and other important factors, include, among others, the risks, uncertainties and factors set forth under “Part II-Item IA. Risk Factors” of this Quarterly Report on Form 10-Q and under “Part I-Item IA. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, including the risks and uncertainties related to the following: (a) the impact of the COVID-19 pandemic; (b) accidents, unplanned production shutdowns or disruptions in any of the Company’s manufacturing facilities; (c) reduced demand for Company products due to customer product reformulations or new technologies; (d) the Company’s inability to successfully develop or introduce new products; (e) compliance with anti-corruption, environmental, health and safety and product registration laws; (f) the Company’s ability to make acquisitions of suitable candidates and successfully integrate acquisitions; (g) global competition and the Company’s ability to successfully compete; (h) volatility of raw material, natural gas and electricity costs as well as any disruption in their supply; (i) disruptions in transportation or significant changes in transportation costs; (j) downturns in certain industries and general economic downturns; (k) international business risks, including fluctuations in currency exchange rates, legal restrictions and taxes; (l) unfavorable resolution of litigation against the Company; (m) the Company’s ability to keep and protect its intellectual property rights; (n) potentially adverse tax consequences due to the international scope of the Company’s operations; (o) downgrades to the Company’s credit ratings or disruptions to the Company’s ability to access well-functioning capital markets; (p) conflicts, military actions, terrorist attacks and general instability, particularly in certain energy-producing nations, along with increased security regulations; (q) cost overruns, delays and miscalculations in capacity needs with respect to the Company’s expansion or other capital projects; (r) interruption of, damage to or compromise of the Company’s IT systems and failure to maintain the integrity of customer, colleague or Company data; (s) the Company’s ability to retain its executive management and other key personnel, and; (t) the Company’s ability to operate within the limitations of its debt covenants.

These factors are not necessarily all of the important factors that could cause the Company’s actual financial results, performance, achievements or prospects to differ materially from those expressed in or implied by any of its forward-looking statements. Other unknown or unpredictable factors also could harm the Company’s results. All forward-looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and the Company does not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements.

The “Company,” “we,” “our” or “us” means Stepan Company and one or more of its subsidiaries only.

Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

  • Surfactants – Surfactants, which accounted for 72 percent of Company consolidated net sales for the first three months of 2020, are principal ingredients in consumer and industrial cleaning and disinfection products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at five U.S. sites, two European sites (United Kingdom

and France), five Latin American sites (one site in Colombia and two sites in each of Mexico and Brazil) and two Asian sites (Philippines and Singapore). Recent significant events include:

  • On January 19, 2020, the Company experienced a power disruption that impacted its Millsdale, Illinois facility. This power outage combined with below freezing temperatures led to significant production and operational challenges that impacted both Surfactants and Polymers produced at the site. The Millsdale facility operated on a partial basis and used existing inventories to serve its customers. However, on February 17, 2020, power outage-related operational issues impacted the Millsdale site’s waste water treatment plant (WWTP) and forced the Company to stop production at the site. As a result, the Company declared force majeure for the supply of phthalic anhydride (Polymers) and certain surfactant product lines. All production lines were fully operational prior to the end of the first quarter. The Company’s insurance provider has acknowledged this incident is a covered event and the Company is pursuing insurance recovery for incremental supply chain expenses and business interruption.
  • In March 2020 the Company acquired certain assets of Logos Technologies LLC's NatSurFact® business, a rhamnolipid-based line of bio-surfactants derived from renewable sources. These bio-surfactants offer synergies in several strategic end use markets including oilfield, agriculture, personal care and household, industrial and institutional. The Company will focus efforts to further develop, integrate and commercialize these unique surfactants moving forward. The Company believes the rhamnolipid technology will further advance the growth and sustainability aspirations of both the Company and its customers. (See Note 17, Acquisitions, for additional details).
  • In December 2019 the Company acquired an oilfield demulsifier product line. The Company believes this acquisition will accelerate its strategy to diversify into additional application segments with the oilfield markets. The acquired business did not impact the Company’s 2019 financial results nor is it expected to be accretive to earnings in 2020 (see Note 17, Acquisitions, for additional details).
  • During the fourth quarter of 2018, the Company shut down Surfactant operations at its plant site in Germany. The Company ceased Surfactant production at this site to further reduce its fixed cost base, refocus Surfactant resources on higher margin end markets and allow for select assets to be repurposed to support future polyol growth. Decommissioning costs associated with the shutdown were incurred in 2019 and will continue in 2020 (see Note 16, Business Restructuring, for additional details).
  • Polymers – Polymers, which accounted for 24 percent of consolidated net sales for the first three months of 2020, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively, CASE products). Powdered polyester resins are used in coating applications. CASE and powdered polyester resins are collectively referred to as specialty polyols. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the United States, polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and specialty polyols are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyurethane polyols are manufactured by the Company’s subsidiary in Germany, and specialty polyols are manufactured by the Company’s Poland subsidiary. In China, polyurethane polyols and specialty polyols are manufactured at the Company’s Nanjing, China, plant. Recent significant events include:
  • The operational issues at the Company’s Millsdale, Illinois facility, described in the significant event paragraph above, negatively impacted Polymers earnings during the first quarter of 2020.
  • Specialty Products – Specialty products, which accounted for four percent of consolidated net sales for the first three months of 2020, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors. Recent significant events include:
  • During 2019, the Company restructured its Specialty Products office in the Netherlands and eliminated positions from the site’s supply chain, quality control and research and development areas. This restructuring was undertaken to better align the number of personnel with current business requirements and reduce costs at the site (see Note 16, Business Restructuring, for additional details).

2020 Acquisition

On March 13, 2020, the Company acquired certain assets of Logos Technologies LLC's NatSurFact® business, a rhamnolipid-based line of bio-surfactants derived from renewable sources. These bio-surfactants offer synergies in several strategic end use markets including oilfield, agriculture, personal care and household, industrial and institutional. The acquisition was accounted for as an asset acquisition. The purchase price of the acquisition was $2,040,000 and was paid with cash on hand. All assets acquired are included in the Company’s Surfactants segment. The assets acquired were primarily intangibles, including trademarks and know-how ($1,071,000) and patents ($357,000). Additionally, $612,000 of laboratory equipment was acquired.

Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

(In millions)

Income (Expense) For the Three Months Ended March 31 2020 2019 Change
Deferred Compensation (Administrative expense) $7.3 $(7.5) $14.8
Realized/Unrealized Gains (Losses) on Investments (Other, net) (3.6) 2.3 (5.9)
Investment Income (Other, net) 0.1 0.1 -
Pretax Income Effect $3.8 $(5.1) $8.9

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income statement line items for the three months ended March 31, 2020 and 2019:

(In millions)

Three Months Ended March 31 2020 2019 Increase (Decrease) (Decrease) Due to Foreign Translation
Net Sales $450.0 $489.2 $(39.2) $(8.2)
Gross Profit 79.3 84.6 (5.3) (1.4)
Operating Income 40.0 29.7 10.3 (0.8)
Pretax Income 35.5 31.0 4.5 (0.8)

RESULTS OF OPERATIONS

Three Months Ended March 31, 2020 and 2019

Summary

Net income attributable to the Company for the first quarter of 2020 increased 10 percent to $27.5 million, or $1.18 per diluted share, from $25.0 million, or $1.07 per diluted share, for the first quarter of 2019. Adjusted net income decreased 21 percent to $24.2 million, or $1.04 per diluted share, from $30.6 million, or $1.31 per diluted share in 2019 (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for a reconciliation between reported net income attributable to the Company and reported earnings per diluted share and non-GAAP adjusted net income and adjusted earnings per diluted share). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first quarter of 2020 compared to the first quarter of 2019 follows the summary.

Consolidated net sales decreased $39.2 million, or eight percent, between quarters. Lower average selling prices negatively impacted the quarter-over-quarter change in net sales by $18.0 million. The decrease in average selling prices was primarily due to the pass through of lower raw material costs. Consolidated sales volume decreased three percent, which had a $13.0 million unfavorable impact on the quarter-over-quarter change in net sales. Most of the sales volume decline resulted from the production and operational issues at the Company’s Millsdale, IL facility in the first quarter of 2020. Sales volume decreased for each of the three segments. Foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $8.2 million due to a stronger U.S. dollar against most currencies where the Company has foreign operations.

Operating income for the first quarter of 2020 increased $10.3 million, or 35 percent, versus operating income for the first quarter of 2019. Most of this increase reflects lower deferred compensation expenses in 2020. Deferred compensation expenses declined $14.8 million quarter-over-quarter. From a segment perspective, Polymer and Surfactant operating income declined $4.6 million and $1.0 million, respectively. Specialty Products operating income improved $0.9 million. Business restructuring expenses were $0.4 million lower in the current year quarter and corporate expenses (excluding deferred compensation and business restructuring expense) were relatively flat with prior year. Foreign currency translation had a $0.8 million unfavorable impact on consolidated operating income quarter-over-quarter.

Operating expenses (including deferred compensation and business restructuring expense) decreased $15.6 million, or 28 percent, between quarters. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

  • Selling expenses decreased $0.4 million, or three percent, quarter-over-quarter.
  • Administrative expenses decreased $0.4 million, or two percent, quarter-over-quarter.
  • Research, development and technical service (R&D) expenses increased $0.4 million, or three percent, quarter-over-quarter.
  • Deferred compensation expense decreased $14.8 million, quarter-over-quarter, primarily due to a $13.98 per share decrease in the market price of Company common stock in the first quarter 2020 compared to a $13.52 per share increase in the first quarter of 2019. See the Overview and Segment Results-Corporate Expenses sections of this MD&A for further details.
  • Business restructuring expenses totaled $0.4 million in the first quarter of 2020 versus $0.7 million in 2019. The 2020 restructuring expenses included ongoing decommissioning costs associated with the Company’s manufacturing facility in Canada that ceased operations in the fourth quarter of 2016 ($0.3 million) and decommissioning costs associated with Company’s 2018 sulfonation shut down in Germany ($0.1 million). The 2019 restructuring charges were primarily comprised of severance and office shutdown expenses related to restructuring efforts within Specialty Products ($0.5 million) and decommissioning costs associated with the Canadian plant closure ($0.3 million).

Net interest expense for the first quarter of 2020 decreased $0.6 million, or 34 percent, versus the first quarter of 2019. This decrease was primarily attributable to lower interest expense resulting from scheduled debt repayments and the Company’s voluntary prepayment of its 5.88 percent Senior Notes in the second quarter of 2019. Partially offsetting the above was lower interest income which reflects lower interest rates due to global market conditions.

Other, net was $3.3 million of expense in the first quarter of 2020 versus $3.1 million of income in the first quarter of 2019. The Company recognized $3.8 million of investment losses (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the first quarter of 2020 compared $2.5 million of investment income in last year’s first quarter. In addition, the Company reported $0.6 million of foreign exchange gains in both the first quarter of 2020 and 2019. The Company also reported $0.1 million of higher net periodic pension cost expense in the first quarter of 2020 versus the prior year.

The Company’s effective tax rate was 22.5 percent in the first quarter of 2020 versus 19.5 percent in the first quarter of 2019. The quarter-over-quarter increase was primarily attributable to lower tax benefits derived from stock-based compensation awards exercised or distributed in the first quarter of 2020 versus the first quarter of 2019.

Segment Results

(Dollars in thousands)

Net Sales For the Three Months Ended March 31, 2020 March 31, 2019 (Decrease) Percent Change
Surfactants $327,071 $349,650 $(22,579) -6
Polymers 106,491 120,179 (13,688) -11
Specialty Products 16,425 19,341 (2,916) -15
Total Net Sales $449,987 $489,170 $(39,183) -8

(Dollars in thousands)

Operating Income For the Three Months Ended March 31, 2020 March 31, 2019 Increase (Decrease) Percent Change
Surfactants $36,156 $37,167 $(1,011) -3
Polymers 7,516 12,105 (4,589) -38
Specialty Products 3,984 3,131 853 NM
Segment Operating Income $47,656 $52,403 $(4,747) -9
Corporate Expenses, Excluding Deferred Compensation and Restructuring 14,618 14,459 159 1
Deferred Compensation Expense (7,323) 7,473 (14,796) -198
Business Restructuring 357 733 (376) -51
Total Operating Income $40,004 $29,738 $10,266 35

Surfactants

Surfactants net sales for the first quarter of 2020 decreased $22.6 million, or six percent, versus net sales for the first quarter of 2019. The unfavorable impact of lower selling prices, foreign currency translation and lower selling prices negatively impacted the quarter-over-quarter change in net sales by $12.7 million, $6.5 million and $3.4 million, respectively. A quarter-over-quarter comparison of net sales by region follows:

(Dollars in thousands)

Net Sales For the Three Months Ended March 31, 2020 March 31, 2019 (Decrease) Percent Change
North America $207,946 $214,297 $(6,351) -3
Europe 59,660 71,478 (11,818) -17
Latin America 46,510 50,812 (4,302) -8
Asia 12,955 13,063 (108) -1
Total Surfactants Segment $327,071 $349,650 $(22,579) -6

Net sales for North American operations decreased $6.4 million, or three percent, between quarters. Lower average selling prices negatively impacted the quarter-over-quarter change in net sales by $8.8 million. Selling prices decreased four percent mostly due to the pass through of lower raw material costs to customers. Sales volume growth of one percent positively impacted the change in net sales by $2.5 million. The sales volume increase was mostly due to higher demand for products sold into the consumer product end markets, driven by increased demand for cleaning and disinfection products as a result of COVID-19, partially offset by lower demand in the functional products end market, principally agricultural and oilfield. Sales volume was also negatively impacted by plant operational issues at the Millsdale, IL site during the first quarter of 2020. Foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $0.1 million.

Net sales for European operations decreased $11.8 million, or 17 percent, between quarters. A 14 percent decline in sales volume, the unfavorable impact of foreign currency translation and lower average selling prices negatively impacted the quarter-over-quarter change in net sales by $9.8 million, $1.5 million and $0.5 million, respectively. The lower sales volume primarily reflects lost business at one customer partially offset by increased demand for cleaning and disinfection products as a result of COVID-19 and higher demand for products sold into the agricultural end markets. A stronger U.S. dollar relative to the European euro and British pound sterling led to the foreign currency translation effect.

Net sales for Latin American operations declined $4.3 million, or eight percent, primarily due to the unfavorable impact of foreign currency translation and lower selling prices. These items negatively impacted the quarter-over quarter change in nets sales by $5.1 million and $2.0 million, respectively. The quarter-over-quarter strengthening of the U.S. dollar against the Brazilian real,

Mexican peso and the Colombian peso generated the unfavorable foreign currency effect. Sales volume grew six percent in the quarter and positively impacted the change in net sales by $2.8 million. This sales volume growth primarily reflects higher demand for products sold into the consumer product end markets, driven by increased demand for cleaning and disinfection products. In addition, prior year sales volume was negatively impacted by a sulfonation equipment failure at the Company’s Ecatepec, Mexico facility.

Net sales for Asian operations were flat quarter-over-quarter. A three percent decline in sales volume was largely offset by the favorable impact of foreign currency translation. The lower sales volume was largely due to lower demand for products sold to our distribution partners partially offset by higher demand for products sold to the agricultural end markets.

Surfactants operating income for the first quarter of 2020 decreased $1.0 million, or three percent, over operating income for the first quarter of 2019. Gross profit declined $1.1 million and operating expenses were slightly lower versus prior year. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(Dollars in thousands)

Gross Profit and Operating Income For the Three Months Ended March 31, 2020 March 31, 2019 Increase (Decrease) Percent Change
North America $41,163 $43,084 $(1,921) -4
Europe 9,498 10,438 (940) -9
Latin America 7,036 3,514 3,522 100
Asia 2,157 3,942 (1,785) -45
Surfactants Segment Gross Profit $59,854 $60,978 $(1,124) (2)
Operating Expenses 23,698 23,811 (113) 0
Surfactants Segment Operating Income $36,156 $37,167 $(1,011) -3

Gross profit for North American operations decreased $1.9 million, or four percent, between quarters primarily due to lower unit margins. The lower unit margins negatively impacted the change in gross profit by $2.4 million. The lower unit margins principally reflect higher maintenance and supply chain expenses incurred as a result of the incident at the Company’s Millsdale, IL site. Sales volume grew one percent and positively impacted the change in gross profit by $0.5 million. The sales volume increase was mostly due to higher demand for products sold into the consumer product end markets, driven by increased demand for cleaning and disinfection products as a result of COVID-19. Sales volume was negatively impacted by the first quarter operational issues at the Company’s Millsdale, IL facility.

Gross profit for European operations decreased $0.9 million, or nine percent, primarily due a 14 percent decline in sales volume and the unfavorable impact of foreign currency translation. These items negatively impacted the quarter-over-quarter change in gross profit by $1.4 million and $0.3 million, respectively. Higher unit margins positively impacted the quarter-over-quarter change in gross profit by $0.8 million. The higher unit margins were attributable to a more favorable product mix in the first quarter of 2020 primarily resulting from higher demand in the agricultural end markets and lower demand for commodity softeners.

Gross profit for Latin American operations increased $3.5 million, or 100 percent, between quarters primarily due to higher unit margins. Higher unit margins positively impacted the quarter-over-quarter change in gross profit by $4.2 million. The higher unit margins primarily reflect the Company’s Mexican sites being fully operational in 2020 versus 2019 when Mexico incurred higher freight and supply chain expenses as a result of the sulfonation equipment failure at the Company’s Ecatepec, Mexico facility. Sales volume growth of six percent positively impacted the quarter-over-quarter change in gross profit by $0.2 million. The unfavorable impact of foreign currency translation negatively impacted the current year quarter by $0.9 million.

Gross profit for Asia operations decreased $1.8 million, or 45 percent, between quarters largely due to lower unit margins and lower sales volumes. These items negatively impacted gross profit by $1.7 million and $0.1 million, respectively. The lower unit margins are primarily due to higher unit overhead costs in Singapore due to unfavorable production timing differences.

Operating expenses for the Surfactants segment decreased $0.1 million quarter-over-quarter.

Polymers

Polymers net sales for the first quarter of 2020 decreased $13.7 million, or 11 percent, versus net sales for the same period of 2019. A nine percent decrease in sales volume negatively impacted the quarter-over-quarter change in net sales by $10.5 million. The unfavorable impact of foreign currency translation and lower average selling prices negatively impacted the quarter-over-quarter change in net sales by $1.7 million and $1.5 million, respectively. A quarter-over-quarter comparison of net sales by region follows:

(Dollars in thousands)

Net Sales For the Three Months Ended March 31 2020 March 31 2019 Increase (decrease) Percent change
North America $61,841 $71,323 $(9,482) -13
Europe 36,560 42,105 (5,545) -13
Asia and Other 8,090 6,751 1,339 20
Total Polymers Segment $106,491 $120,179 $(13,688) -11

Net sales for North American operations declined $9.5 million, or 13 percent, primarily due to a 14 percent decline in sales volume. The decline in sales volume negatively impacted the quarter-over-quarter change in net sales by $10.2 million. Sales volume of polyols used in rigid foam applications increased four percent during the quarter but was outweighed by a 61 percent decline in phthalic anhydride volume. The phthalic anhydride decrease was largely related to the first quarter 2020 incident at the Company’s Millsdale, IL facility which forced the Company to temporarily halt phthalic anhydride production and declare force majeure for this product line. The Millsdale, IL facility was fully operational prior to the end of the first quarter. Higher average selling prices positively impacted the change in net sales by $0.7 million.

Net sales for European operations declined $5.5 million or 13 percent, quarter-over-quarter. A five percent decrease in sales volume, lower average selling prices and the unfavorable impact of foreign currency translation negatively impacted the change in net sales by $2.2 million, $2.0 million and $1.3 million, respectively. The decline in sales volume principally reflects softer demand due to deferred or canceled construction projects as a result of COVID-19.

Net sales for Asia and Other operations increased $1.3 million, or 20 percent, primarily due to an 18 percent increase in sales volume and higher average selling prices. These two items positively impacted the quarter-over-quarter change in net sales by $1.2 million and $0.5 million, respectively. The higher sales volume was primarily due to higher demand in livestock and cold storage markets. The unfavorable impact of foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $0.4 million.

Polymers operating income for the first quarter of 2020 declined $4.6 million, or 38 percent, versus operating income for the first quarter of 2019. Gross profit decreased $4.7 million, or 24 percent, primarily due to the nine percent decline in sales volume and lower unit margins. The lower unit margins principally reflect higher maintenance, supply chain costs and unit overhead rates incurred as a result of the first quarter 2020 incident at the Company’s Millsdale, IL site. Operating expenses declined two percent quarter-over-quarter. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(Dollars in thousands)

Gross Profit and Operating Income For the Three Months Ended March 31, 2020 March 31, 2019 Increase (Decrease) Percent Change
North America $7,732 $12,966 $(5,234) -40
Europe 5,652 5,609 43 1
Asia and Other 1,131 648 483 75
Polymers Segment Gross Profit $14,515 $19,223 $(4,708) -24
Operating Expenses 6,999 7,118 (119) -2
Polymers Segment Operating Income $7,516 $12,105 $(4,589) -38

Gross profit for North American operations declined $5.2 million, or 40 percent, primarily due to lower unit margins and the 14 percent decline in sales volume. These two items negatively impacted the change in gross profit by $3.4 million and $1.8 million, respectively. Both the decline in margins and volume resulted from the first quarter 2020 incident at the Company’s Millsdale, IL facility which forced a temporary production shutdown and resulted in higher maintenance, supply chain costs and unit overhead rates.

Gross profit for European operations was flat between quarters. Higher unit margins positively impacted the quarter-over-quarter change in gross profit by $0.5 million. These higher unit margins reflect lower overhead in the current year due to the non-recurrence of a maintenance shutdown in Germany in the first quarter of 2019. These higher unit margins were offset by a five percent decline in sales volume and the unfavorable impact of foreign currency translation. These items negatively impacted the change in gross profit by $0.3 million and $0.2 million respectively. The decline in sales volume principally reflects softer demand due to deferred or canceled construction projects as a result of COVID-19.

Gross profit for Asia and Other operations improved $0.5 million primarily due higher unit margins and sales volume growth of 18 percent.

Operating expenses for the Polymers segment decreased $0.1 million, or two percent, quarter-over-quarter.

Specialty Products

Specialty Products net sales decreased $2.9 million, or 15 percent, versus net sales in the first quarter of 2019 due to an eight percent decrease in sales volume and lower average selling prices. Gross profit and operating income each increased by $0.9 million. These increases primarily reflect improved margins and volume within the Company’s medium chain triglycerides product line driven by strong demand in the infant nutrition market.

Corporate Expenses

Corporate expenses, which include deferred compensation, business restructuring and other operating expenses that are not allocated to the reportable segments, decreased $15.0 million between quarters. Corporate expenses were $7.7 million in the first quarter of 2020 versus $22.7 million in 2019. This decrease was primarily attributable to lower deferred compensation ($14.8 million) and business restructuring ($0.4 million) expenses in 2020.

The $14.8 million decrease in deferred compensation expense was primarily due to a $13.98 per share decline in the market price of Company common stock in the first quarter of 2020 compared to a $13.52 per share increase in the first quarter of 2019. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expenses for the three months ended March 31, 2020 and 2019:

2020 March 31 2019 December 31 March 31 2018 December 31
Company Common Stock Price $88.46 $102.44 $87.52 $74.00

LIQUIDITY AND CAPITAL RESOURCES

Overview

For the three months ended March 31, 2020, operating activities were a cash outflow of $6.5 million versus a cash source of $4.4 million for the comparable period in 2019. For the current year period, investing cash outflows totaled $32.9 million versus a cash outflow of $23.7 million in the prior year period. Financing activities were a use of $14.4 million versus a use of $10.8 million in the prior year period. Cash and cash equivalents decreased by $61.0 million compared to December 31, 2019, inclusive of a $7.2 million unfavorable exchange rate impact.

At March 31, 2020, the Company’s cash and cash equivalents totaled $254.3 million, of which $155.4 million was held within the United States. Cash in U.S. money market funds which were rated AAAm by Standard and Poor’s, Aaa-mf by Moody’s and AAAmmf by Fitch totaled $71.8 million. Cash in U.S. demand deposit accounts and a certificate of deposit totaled $83.6 million. The Company’s non-U.S. subsidiaries held $98.9 million of cash outside the United States as of March 31, 2020.

Operating Activity

Net income increased by $2.6 million versus the comparable period in 2019. Working capital was a cash use of $51.0 million in 2020 versus a use of $46.7 million in 2019.

Accounts receivable were a use of $30.8 million in 2020 compared to a use of $17.4 million for the comparable period of 2019. Inventories were a use of $0.4 million in 2020 versus a source of $16.2 million in 2019. Accounts payable and accrued liabilities were a use of $16.6 million in 2020 compared to a use of $42.3 million for the same period in 2019.

Working capital requirements were higher in 2020 compared to 2019 primarily due to the changes noted above. The higher accounts receivables cash usage in 2020 was primarily due to higher sales volume within the consumer product end markets during the latter portion of the first quarter to support increased demand for cleaning and disinfection products as a result of COVID-19. The current year’s lower accounts payable and accrued liabilities cash usage reflect a build-up of raw material inventories in the first quarter of 2020 versus a reduction of raw material inventories in 2019. A portion of the 2020 raw material inventory build was undertaken to support the higher finished goods demand within the consumer product end markets. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital requirements during 2020.

Investing Activity

Cash used for investing activities increased $9.2 million year-over-year. In the first quarter of 2020, the Company acquired certain assets of Logos Technologies LLC's NatSurFact® rhamnolipid-based line of bio-surfactants for $2.0 million. Cash used for capital expenditures was $33.2 million in the first quarter of 2020 versus $25.7 million in the comparable prior year period.

For 2020, the Company estimates that total capital expenditures will range from $100 million to $120 million including infrastructure and optimization spending in the United States, Germany and Mexico.

Financing Activity

Cash used for financing activities was $14.4 million in 2020 versus $10.8 million in 2019. Most of this increase reflects a higher level of share repurchases during the first quarter of 2020 compared to 2019.

The Company purchases shares of its common stock in the open market or from its benefit plans from time to time to fund its own benefit plans and to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may, from time to time, seek to retire or purchase additional amounts of its outstanding equity and/or debt securities through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise, including pursuant to plans meeting the requirements of Rule 10b5-1 promulgated by the SEC. Such repurchases or exchanges, if any, will depend on prevailing market conditions, the Company’s liquidity requirements, contractual restrictions and other factors. The amounts involved may be material. In the three months ended March 31, 2020, the Company purchased 89,225 shares on the open market at a total cost of $7.2 million. At March 31, 2020, there were 260,605 shares remaining under the current share repurchase authorization.

Debt and Credit Facilities

Consolidated balance sheet debt of $222.1 million was unchanged during the first quarter of 2020 compared to December 31, 2019. Net debt (which is defined as total debt minus cash – see the “Reconciliation of Non-GAAP Net Debt” section of this MD&A) increased by $61.1 million in the first quarter of 2020, from a negative $93.3 million to a negative $32.2 million, due to a $61.1 million cash reduction. The first quarter 2020 cash reduction primarily reflects higher working capital requirements which are typical for the Company in the first quarter.

As of March 31, 2020, the ratio of total debt to total debt plus shareholders’ equity was 20.4 percent compared to 19.9 percent at December 31, 2019. As of March 31, 2020, the ratio of net debt to net debt plus shareholders’ equity was negative 3.9 percent, compared to negative 11.7 percent at December 31, 2019. See the “Reconciliation of Non-GAAP Net Debt” section in this MD&A. At March 31, 2020, the Company’s debt included $222.1 million of unsecured private placement loans with maturities ranging from 2020 through 2027 which were issued to insurance companies pursuant to note purchase agreements (the Note Purchase Agreements). These notes are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

On January 30, 2018, the Company entered a five-year committed $350 million multi-currency revolving credit facility with a syndicate of banks that matures on January 30, 2023. This credit agreement allows the Company to make unsecured borrowings, as requested from time to time, to finance working capital needs, permitted acquisitions, capital expenditures and for general corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings. As of March 31, 2020, the Company had outstanding letters of credit totaling $4.9 million under the revolving credit agreement and no borrowings, with $345.1 million remaining available.

The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditures and acquisitions. At March 31, 2020, the Company’s foreign subsidiaries had no outstanding debt.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. As of March 31, 2020, testing for these agreements was based on the Company’s consolidated financial statements. Under the most restrictive of these debt covenants:

1. The Company is required to maintain a minimum interest coverage ratio, as defined within the agreements, of 3.50 to 1.00, for the preceding four calendar quarters.

2. The Company is required to maintain a maximum net leverage ratio, as defined within the agreements, not to exceed 3.50 to 1.00.

3. The Company is required to maintain net worth of at least $325.0 million.

4. The Company is permitted to pay dividends and purchase treasury shares after December 31, 2017, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively beginning December 31, 2017. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 14 to the condensed consolidated financial statements.

The Company believes it was in compliance with all of its loan agreements as of March 31, 2020.

ENVIRONMENTAL AND LEGAL MATTERS

The Company’s operations are subject to extensive federal, state and local environmental laws and regulations and similar laws in the other countries in which the Company does business. Although the Company's environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation may require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first three months of 2020 and 2019, the Company’s expenditures for capital projects related to the environment were $0.7 million and $0.3 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $10.0 million and $7.4 million for the three months ended March 31, 2020 and 2019, respectively.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state or foreign statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it is likely to incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable, and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Estimating the possible costs of remediation required making assumptions related to the nature and extent of contamination and the methods and resulting costs of remediation. Some of the factors on which the Company bases its estimates include information provided by decisions rendered by State and Federal environmental regulatory agencies, information provided by feasibility studies, and remedial action plans developed. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $24.9 million to $43.0 million at March 31, 2020 versus $25.9 million to $43.7 million at December 31, 2019. Within the range of possible environmental losses, management has currently concluded that no single amount is more likely to occur than any other amounts in the range and, thus, has accrued at the lower end of the range; these accruals totaled $24.9 million at March 31, 2020 and $25.9 million at December 31, 2019. Because the liabilities accrued are estimates, actual amounts could differ from the amounts reported. Cash expenditures related to legal and environmental matters were $0.9 million for the three-month period ended March 31, 2020 compared to $0.2 million for the same period in 2019. The majority of the 2020 cash expenditures relate to the Company’s Maywood, New Jersey site.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, management believes that the Company has no liability at these sites and that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, of the Company’s Annual Report on Form 10-K, Legal Proceedings, in this report and in other filings of the Company with SEC, which are available upon request from the Company. See also Note 8, Contingencies, to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

OUTLOOK

Management believes 2020 will be a challenging year as a result of the global pandemic and other factors. However, management also believes that within the current environment the Company is positioned better than many others. Management believes the Company’s Surfactants segment should benefit from higher demand in the consumer product end markets, driven by increased demand for cleaning and disinfection products. With dramatically lower oil prices management believes demand for surfactants in the oilfield end market will be down. Management believes its Polymers segment will be challenged as construction projects are canceled or deferred as a result of COVID-19. The North American business is also expected to incur higher raw material costs due to the Illinois River lock closures scheduled during the second half of 2020. Management believes the long-term prospects for Polymers segment remain attractive because of ongoing energy conservation efforts and more stringent building codes. Management believes full year Specialty Products results will approximate 2019 results.

CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2019 Annual Report on Form 10-K.

RECONCILIATION OF NON-GAAP ADJUSTED NET INCOME AND EARNINGS PER SHARE

(In millions, except per share amounts)

Three Months Ended March 31 2020 Net Income Diluted EPS 2019 Net Income Diluted EPS
Net Income Attributable to the Company as Reported $27.5 $1.18 $25.0 $1.07
Deferred Compensation Expense (including related investment activity) (3.7) (0.16) 5.1 0.22
Business Restructuring 0.4 0.02 0.7 0.03
Cash Settled Stock Appreciation Rights (1.1) (0.04) 1.6 0.07
Cumulative Tax Effect on Above Adjustment Items 1.1 0.04 (1.8) (0.08)
Adjusted Net Income $24.2 $1.04 $30.6 $1.31

The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. These measures should be considered in addition to, not a substitute for or superior to, measures of financial performance prepared in accordance with GAAP. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the noted transactions occurred.

RECONCILIATION OF NON-GAAP NET DEBT

Management uses the non-GAAP net debt metric to gain a more complete picture of the Company’s overall liquidity, financial flexibility and leverage level. This adjusted measure should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP. The Company's definition of this adjusted measure may differ from similarly titled measures used by other entities.

(In millions)

March 31, 2020 December 31, 2019
Current Maturities of Long-Term Debt as Reported $23.6 $23.6
Long-Term Debt as Reported 198.5 198.5
Total Debt as Reported 222.1 222.1
Less Cash and Cash Equivalents as Reported (254.3) (315.4)
Net Debt $(32.2) $(93.3)
Equity $866.8 $891.8
Net Debt plus Equity $834.6 $798.5
Net Debt/(Net Debt plus Equity) -4% -12%

29

Controls and procedures

As filed, 1,285 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of Disclosure Controls and Procedures

We have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of March 31, 2020. Based on this evaluation of our disclosure controls and procedures, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2020, such that the information required to be disclosed in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Exchange Act and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

b. Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 2,603 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the risk factors disclosed in the Company’s 2019 Annual Report on Form 10-K, except for the addition of the following risk factor:

The COVID-19 pandemic could have a material adverse impact on our business, financial position, results of operations and cash flows.

The current novel coronavirus (or COVID-19) pandemic has disrupted our operations and will affect our business, including as a result of government authorities imposing mandatory closures, work-from-home orders and social distancing protocols, or imposing other restrictions that could materially adversely affect our ability to adequately staff and maintain our operations. Specifically, we have experienced a temporary facility closure in response to government mandates in one jurisdiction in which we operate. In addition, for the safety of our employees, we temporarily halted one distinct part of production at one facility in response to positive diagnoses of employees for COVID-19 in that part of the facility. We may experience additional closures in the future. The COVID-19 outbreak could also impact our ability to secure supplies for our facilities and to provide appropriate personal protective equipment for our employees, which could impact our operations. Our operations could also be adversely affected by other impacts of the pandemic, including, among others, disruption of our supply of raw materials and transportation and delivery of our products. The COVID‑19 outbreak, and resulting perceptions of health risks, could have long-term effects on our customers and the economies of countries in which we and our customers operate, and demand for our products could be adversely affected. Because the Company cannot predict the duration, scope or broader impact of the COVID-19 pandemic, the impact on the Company cannot be reasonably estimated, but the pandemic could have a material adverse effect on the Company’s business, financial position, results of operations and cash flows.

In addition, we cannot predict the impact that COVID-19 will have on our customers, suppliers, vendors, and other business partners, and each of their financial conditions; however, any material effect on these parties could adversely impact us. The impact of COVID-19 may also exacerbate other risks discussed under “Part I-Item IA. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, any of which could have a material effect on us. This situation is changing rapidly and additional impacts of which we are not currently aware may arise.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-01-01 to 2020-03-31$450.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-01-01 to 2020-03-31$370.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-01-01 to 2020-03-31$79.3mus-gaap:GrossProfit
Operating income3 months2020-01-01 to 2020-03-31$40.0mus-gaap:OperatingIncomeLoss
Income tax3 months2020-01-01 to 2020-03-31$8.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-01-01 to 2020-03-31$27.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-01-01 to 2020-03-31$1.18us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-01-01 to 2020-03-31$1.20us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-01-01 to 2020-03-3123,285,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2020-01-01 to 2020-03-31−$6.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-01-01 to 2020-03-31$33.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2020-01-01 to 2020-03-31$6.2mus-gaap:PaymentsOfDividends
Share repurchases3 months2020-01-01 to 2020-03-31$7.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-03-31$254.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-03-31$768.5mus-gaap:AssetsCurrent
Total assetsAt period end2020-03-31$1.51bnus-gaap:Assets
Current liabilitiesAt period end2020-03-31$310.2mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-03-31$198.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-03-31$23.6mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-03-31$866.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-020009. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.